C4orf28 Inhibitors
Chemical inhibitors of C4orf28 can profoundly alter the protein's function through various modes of action, each targeting specific cellular signaling pathways or enzymes. Alsterpaullone and Roscovitine, for instance, are cyclin-dependent kinase inhibitors. By inhibiting CDKs, these chemicals can prevent the progression of the cell cycle, thereby inhibiting the functional role of C4orf28 if it is indeed involved in this process. LY294002 and Wortmannin both target the phosphatidylinositol 3-kinase (PI3K) pathway, another critical signaling pathway that influences various cellular functions. If C4orf28's role is connected to the PI3K/Akt pathway, the inhibition of PI3K by these chemicals would disrupt the functional activity of the protein.
Additional inhibitors like SP600125 and SB203580 specifically target kinases involved in stress and inflammatory responses, namely, the c-Jun N-terminal kinase (JNK) and the p38 MAP kinase, respectively. The inhibition of these kinases would prevent the activation of downstream signaling components that C4orf28 may be a part of, leading to its functional inhibition. PD98059 and U0126, which selectively inhibit MEK, would lead to a similar outcome if C4orf28 is associated with the MAPK/ERK pathway by preventing the activation of ERK. On another front, Rapamycin, an mTOR inhibitor, can suppress the functional role of C4orf28 if it is linked to mTOR-related pathways that are central to cell growth and metabolism. Lastly, Y-27632 and SB431542 target the Rho/ROCK pathway and TGF-beta signaling pathway, respectively. If C4orf28's activity involves these pathways, the inhibition by these chemicals would disrupt its functional role, with Y-27632 inhibiting processes regulated by the Rho/ROCK pathway and SB431542 affecting TGF-beta signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone inhibits cyclin-dependent kinases (CDKs), which are essential regulators of cell cycle progression. C4orf28 may be involved in cell cycle regulation; therefore, by inhibiting CDKs, alsterpaullone indirectly inhibits the function of C4orf28 by preventing cell cycle progression where C4orf28 may have a functional role. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is another CDK inhibitor that works by inhibiting CDK1, CDK2, CDK5, and CDK7. If C4orf28 is involved in cell cycle control or transcriptional regulation through CDKs, roscovitine would indirectly inhibit C4orf28 activity by blocking the CDKs that are required for its functional role. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is involved in stress signaling pathways that can influence cell cycle and apoptosis. C4orf28, if participating in these pathways, would have its function inhibited by SP600125 through the prevention of JNK-mediated signaling events. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphatidylinositol 3-kinase (PI3K) inhibitor. If C4orf28 function is linked to the PI3K/Akt signaling pathway, which is involved in numerous cellular processes including metabolism, cell growth, and survival, then LY294002 would inhibit C4orf28 by blocking this pathway's activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of mitogen-activated protein kinase kinase (MEK), which is part of the MAPK/ERK pathway. Inhibition of MEK, and thus the MAPK/ERK pathway, by PD98059 would lead to functional inhibition of C4orf28 if it is involved in this particular signaling cascade. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase, which plays a role in cellular responses to stress and inflammation. Inhibiting p38 MAP kinase with SB203580 would result in functional inhibition of C4orf28 if C4orf28 is involved in pathways or processes that are dependent on p38 MAP kinase activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor. Similar to LY294002, if C4orf28 is reliant on the PI3K/Akt pathway for its function, then inhibition of this pathway by wortmannin would result in the functional inhibition of C4orf28. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1 and MEK2, which are crucial components of the MAPK/ERK pathway. By inhibiting these kinases, U0126 prevents the activation of ERK, thereby potentially inhibiting C4orf28 if it is functionally associated with the MAPK/ERK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mammalian target of rapamycin (mTOR), a central regulator of cell growth and metabolism. If C4orf28 is part of pathways regulated by mTOR, its inhibition by rapamycin would lead to functional inhibition of C4orf28 by halting processes that are mTOR dependent. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is an inhibitor of the Rho-associated protein kinase (ROCK). If C4orf28 is involved in cell shape, motility, or proliferation processes regulated by the Rho/ROCK pathway, then its function would be inhibited by Y-27632 through the inhibition of this pathway's activity. | ||||||